Federal Health Grants

This grant provides funding for research projects that explore how climate change affects cancer risks and care, particularly focusing on vulnerable populations and aiming to reduce health disparities.

This funding opportunity provides financial support to public and nonprofit organizations to deliver comprehensive primary health care services in underserved communities across the United States.

The activity seeks to achieve improved TB and HIV/AIDS client outcomes through supporting community-led monitoring activities that will lead to improvements in health service quality. This activity will bolster community leadership, support robust community health sector engagement and increase community participation inhealth system decision-making. Specifically, the activity will: (1) enhance the functionality and coordination of networks of community-led and community-based organizations engaged in the TB and HIV response; (2) strengthen existing platforms to collect and analyze data to inform TB and HIV programming; and (3) bolster the capacity of community-based organizations to carry out data-driven advocacy at the national and local levels.

The U.S. Department of State, U.S. Embassy in Kinshasa - Democratic Republic of Congo through the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR) Coordination Office (PCO) is pleased to announce an open Notification of Funding Opportunity (NOFO) for organizations to submit applications that support Community - led Monitoring (CLM) activities, to be implemented in close collaboration with local Community-based organizations and other civil society groups, networks of key populations (KP), people living with HIV (PLHIV), youth and adolescents including children and other HIV-affected groups. The CLM program will be implemented in the three PEPFAR provinces including Kinshasa, Haut-Katanga and Lualaba. Community-led monitoring or CLM is a routinized process initiated and implemented by local HIV-positive and HIV-affected communities, community-based organizations and other civil society groups that identifies HIV service delivery successes, diagnoses problems, uses quantitative and qualitative data to overcome barriers and ensure that HIV service beneficiaries receive optimal client-centered services. The intention of CLM is for local community leadership to get inputs from recipients and providers of HIV services, including key populations and underserved groups, in a routine and systematic manner and translate their findings into action and change in collaboration with host governments and health systems. CLM is a tool within the community engagement process, a strategic collaboration of multiple partnerships within a designated geographic location. CLM leverages community engagement to empower community members to identify successes, diagnose problems, use data-driven approaches to overcome barriers, and ensure beneficiaries receive optimal client-centered services in a productive, collaborative, respectful, and solutions-oriented manner. This community-driven approach to addressing health challenges often evolves into advocacy, whether driven by the individual, community, organizations, or institutions. The CLM program is funded through the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). The goal of PEPFAR in DRC is to support efforts to achieve HIV epidemic control through implementation of evidence-based interventions to drive progress in HIV prevention, care and treatment and ultimately, save lives. Through the PEPFAR Coordination Office, the U.S. Embassy in Kinshasa administers this Community grants program and is seeking proposals from registered local Community-based organizations and other civil society groups, networks of key populations (KP), people living with HIV (PLHIV), youth and adolescents including children and other HIV-affected groups, or community entities that gather quantitative and qualitative data about HIV services and whose mission and activities focuses on HIV programming. CLM plays key role to ensuring availability, accessibility, affordability, acceptability, and delivery of timely and quality HIV care and services. CLM will raise public awareness on the rights of PLHIV, KP groups, youth and adolescents and other affected communities, will empower beneficiaries and affected communities to speak out, to increase health literacy, to expand engagement with health service providers, to support demand creation, on one hand; and on the other hand, CLM will hold decisions makers accountable for executing changes to improve HIV service delivery. CLM data will be collected using standardized tools and synthesized through a variety of methods that reveal insights from communities about problems and solutions to health and HIV service delivery at: the facility, community, sub-national and national levels. Thus, CLM data builds evidence on what works well, what is not working and what needs to be improved, with suggestions for targeted action to improve outcomes. Monitoring data should reflect an added value and not duplicate collection of routine data already available to PEPFAR, through its standard reporting. Added value monitoring data includes, but not limited to information from beneficiaries about their experience with the health facility, information about barriers and enablers to access and retention in services etc. CLM mechanisms must be routine to ensure follow up and continuous improvement for sustainability. Results from CLM will be shared with all the stakeholders including host governments, health systems, PEPFAR implementing partners and the PEPFAR team on a regular and systematic basis (monthly, quarterly, and annually), for informing decisions, to improve time and quality service delivery.

ATTENTION: All Interested PartiesThe United States Government, represented by the U.S. Agency for International Development (USAID)/Afghanistan, is seeking input from interested organizations and individuals who may provide information, opinions, and recommendations in response to the questions outlined in this RFI for potential USAID interventions to increase equitable access to and utilization of quality health and nutrition services and adoption of healthy behaviors, especially for women and children in targeted areas. This is not a solicitation. This Request for Information (RFI) notice is solely issued for information and planning purposes only. Responses to this notice are not considered an application and will not be accepted or evaluated by the Government as a result of this RFI. Only responses with the information requested in this RFI will be reviewed. Responses received may be used for planning and design purposes. USAID is exploring the design of a new health activity to increase equitable access to and utilization of quality health and nutrition services and adoption of healthy behaviors, especially for women and children. This RFI solicits information, opinions and recommendations from interested organizations and individuals related to the questions below.Please refer to the attached RFI document for more details.

This Annual Program Statement (APS) offers USAID Operating Units a mechanism to facilitate assistance awards to local and non-traditional partners for innovative, adaptive, and locally led development approaches. OUs may issue addenda under this umbrella to solicit, co-create, and fund a wide range of flexible and innovative approaches to locally led development related to their specific priorities, objectives, and programs. The APS aims to advance USAIDs capability to work with local partners, to learn from these engagements, and to share this learning broadly. INTERESTED APPLICANTS - PLEASE READ: This Locally Led Development APS is not a Request for Applications or a Request for Proposals, and this APS does not serve as a general request for locally led development concepts. Do not email concepts to LLD-APS@usaid.gov or submit concepts via grants.gov, as they will not be accepted. Interested Applicants must respond to specific documents that share USAID priorities in a specific country(ies) called addenda that may be issued throughout the year on grants.gov. These addenda, when added, can be found under Related Documents on this page. Please visit this page periodically for opportunities that may be relevant to your country and focus areas. Please see the attachment for further detailed information. This APS was last updated April 26, 2024, with Amendment 1 - 7200AA19APS00007 Locally Led Development Annual Program Statement (APS) 2024-4-26

This funding opportunity supports research that investigates how sex and gender differences impact health outcomes and disease management, targeting a wide range of eligible organizations, including universities and nonprofits.

This funding opportunity supports a variety of organizations in developing and testing new clinical applications derived from basic research to improve health outcomes for individuals with communication disorders.

The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.

The National Institute on Alcohol Abuse and Alcoholism ( NIAAA) intends to reissue RFA-AA-23-001, Specialized Alcohol Research Centers (P50, Clinical Trial Optional), by publishing a NOFO to solicit applications for a broad-based Alcohol Research Centers program to foster and conduct interdisciplinary, collaborative research on Alcohol Use Disorder (AUD), alcohol misuse and alcohol-related problems, and other health-related consequences across the lifespan. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Spring 2024 with an expected application due date in Fall 2024. This NOFO will utilize the P50 activity code. Details of the planned NOFO are provided below.

The NIH Directors Pioneer Award Program supports individual scientists of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. To support innovative and novel research across the vast NIH mission, individuals from diverse backgrounds (including those from underrepresented groups; see Notice of NIHs Interest in Diversity) and from the full spectrum of eligible institutions in all geographic locations are encouraged to apply to this Notice of Funding Opportunity. Applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. The NIH Directors Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

This grant provides funding to higher education institutions and nonprofit organizations to train future professionals in vocational rehabilitation services for individuals with disabilities, addressing personnel shortages in the field.

This funding opportunity provides financial support to organizations implementing strategies to prevent diabetes and improve health equity for populations at risk, focusing on statewide, local, or multisectoral approaches.

This funding opportunity supports research centers focused on understanding how biological sex differences affect women's health, promoting interdisciplinary collaboration and workforce diversity in the scientific community.

This funding opportunity supports the establishment of a center that fosters collaboration between researchers in substance use epidemiology and prevention to develop effective strategies for preventing substance use and related issues.

This funding opportunity provides financial support to state and tribal governments to improve prescription drug monitoring systems, enhance data sharing, and combat the misuse of controlled substances, particularly opioids.

trainer program to educate, train, and prepare jail and prison staff so they are equipped to appropriately interact with people in a carceral setting who have mental illness (MI) and intellectual and developmental disabilities (IDD). This training should be developed by an institution of higher education or non-profit, for profit or tribal in conjunction with health care and corrections professionals to ensure a multidisciplinary approach. The training must focus on understanding behavioral health, including MI and substance use disorders, IDD, developing empathy, navigating community resources, and de-escalation skills and practical application training of those skills in a trauma-informed manner for all staff working in prisons and jails. The centerpiece of this training must be a 40-hour CIT train-the-trainer program.

Synopsis: NOFO # DD24-0051 solicits non-research, cooperative agreement applications to conduct population-based surveillance of congenital heart defects (CHD) to describe health outcomes including health equity, with the goal of identifying opportunities to improve the health of all people living with CHD. This project will involve a required component (A) and an optional component (B). The population included in this surveillance activity can be an entire state or a region within a state. Individuals with CHD should be identified through existing data sources including the jurisdiction birth defects surveillance system, electronic health records, administrative data (e.g., Medicaid/Medicare, hospital discharge), or other sources available to funding recipients. Background: Congenital heart defects (CHD) affect about 1% of all births in the United States, and are a leading cause of birth defect-associated infant mortality, morbidity, and healthcare costs. Improvements in early detection and treatment of CHD and consequently in survival have resulted in many people, including those affected by a severe CHD, living into adolescence and adulthood. An estimated two million persons in the U.S. are living with a CHD, including over one million adults; about 12% of these affected adults have a severe CHD. Most current efforts to conduct population-based surveillance of CHD have focused on monitoring newborns. However, little data exist on the descriptive epidemiology of CHD beyond early childhood in the U.S. Despite the public health burden, the lack of population-based surveillance precludes reliable data on people with CHD, their survival, healthcare utilization, and characteristics associated with long-term outcomes. Through this surveillance activity, these data will be assessed, enabling and informing efforts to improve the health and well-being of people with CHD. Objectives: Component A objectives include: (1) assess survival, comorbidities, healthcare utilization during the period 2021-2023, and characteristics associated with long-term outcomes among people with CHD; (2) assess health equity among people with CHD; (3) examine state and national healthcare policies that have an impact on people with CHD; (4) examine COVID-19 and related data such as health care utilization during the pandemic among people with CHD; and (5) work with local/state partners to use site-specific CHD data. Component B objectives include: (1) develop and refine a machine learning algorithm for the surveillance data collected through Component A; and (2) apply this machine learning algorithm to data collected from all recipients funded through Component A.

This funding opportunity supports experienced researchers looking to expand their expertise or shift their career focus through advanced training and research experiences at various institutions.

The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.